Concurrent Nab-Paclitaxel/Carboplatin Combined with Thoracic Radiotherapy in Locally Advanced Squamous Cell Lung Cancer (NCT01494415)

被引：0
|
作者：
Wu, Kan [1 ]
Xia, Bing [1 ]
Chen, Xueqin [2 ]
Xu, Xiao [1 ]
Wang, Bing [1 ]
Chen, Peng [1 ]
Le, Wenxin [1 ]
Zhang, Minna [1 ]
Ma, Shenglin [2 ]
机构：
[1] Hangzhou Canc Hosp, Hangzhou PeopleS Hosp 1, Hangzhou, Zhejiang, Peoples R China
[2] Hangzhou First PeopleS Hosp, Hangzhou, Zhejiang, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
concurrent chemoradiotherapy; Squamous cell lung cancer; nab-paclitaxel;
D O I：
10.1016/j.jtho.2016.11.2079
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PUB108
引用
收藏
页码：S1509 / S1510
页数：2
相关论文
共 50 条
  • [31] nab-Paclitaxel/Carboplatin in Vulnerable Populations With Advanced Non-Small Cell Lung Cancer: Pooled Analysis
    Langer, Corey J.
    Gajra, Ajeet
    Gridelli, Cesare
    Konduri, Kartik
    Morgensztern, Daniel
    Spigel, David
    Talbot, Denis
    Thomas, Michael
    Weiss, Jared
    Pilot, Richard
    Bhore, Rafia
    Wolfsteiner, Marianne
    Ong, Teng Jin
    Socinski, Mark
    FRONTIERS IN ONCOLOGY, 2021, 10
  • [32] A randomized phase II clinical trial of nab-paclitaxel and carboplatin compared with gemcitabine and carboplatin as first-line therapy in locally advanced or metastatic squamous cell carcinoma of lung
    Jin-Ji Yang
    Cheng Huang
    Gong-Yan Chen
    Yong Song
    Ying Cheng
    Hong-Hong Yan
    Qing Zhou
    Yi-Long Wu
    BMC Cancer, 14
  • [33] A randomized phase II clinical trial of nab-paclitaxel and carboplatin compared with gemcitabine and carboplatin as first-line therapy in locally advanced or metastatic squamous cell carcinoma of lung
    Yang, Jin-Ji
    Huang, Cheng
    Chen, Gong-Yan
    Song, Yong
    Cheng, Ying
    Yan, Hong-Hong
    Zhou, Qing
    Wu, Yi-Long
    BMC CANCER, 2014, 14
  • [34] Endostatin Combined with Paclitaxel, Carboplatin, and Radiotherapy in Patients with Unresectable Locally Advanced Non-Small Cell Lung Cancer
    Sun, Xiao-Jiang
    Deng, Qing-Hua
    Yu, Xin-Min
    Ji, Yong-Lin
    Zheng, Yuan-Da
    Jiang, Hao
    Xu, Yaping
    Ma, Sheng-Lin
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S289 - S290
  • [35] nab-Paclitaxel for the Treatment of Advanced Squamous Non-Small-Cell Lung Cancer: A Comprehensive Update
    Simon, George R.
    CLINICAL LUNG CANCER, 2014, 15 (06) : 391 - 397
  • [36] Multicentre Phase II Trial of Paclitaxel and Carboplatin with Concurrent Radiotherapy in Locally Advanced Non-small Cell Lung Cancer
    Tell, Roger
    Sederholm, Christer
    Klintenberg, Claes
    Franksson, Lars
    Branden, Eva
    Hillerdal, Gunnar
    Lonn, Ulf
    Linden, Carl-Johan
    Ewers, Sven-Borje
    Lamberg, Kristina
    Mrazek, Eva
    Loden, Britta
    Sjogren, Anders
    Linne, Thomas
    Friesland, Signe
    Sirzen, Florin
    ANTICANCER RESEARCH, 2008, 28 (5B) : 2851 - 2857
  • [37] Neoadjuvant radiotherapy concurrent with weekly paclitaxel and carboplatin and followed by surgery in locally advanced non-small-cell lung cancer
    Kuten, A
    Anacak, Y
    Abdah-Bortnyak, R
    Chetver, L
    Al Deen, IZ
    Daoud, K
    Nijem, R
    Billan, S
    Best, L
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2003, 26 (02): : 184 - 187
  • [38] nab-Paclitaxel/carboplatin in elderly patients with advanced squamous non-small cell lung cancer: a retrospective analysis of a Phase III trial
    Gridelli, Cesare
    Chen, Tianlei
    Ko, Amy
    O'Brien, Mary E.
    Ong, Teng Jin
    Socinski, Mark A.
    Postmus, Pieter E.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 12 : 1445 - 1451
  • [39] A phase I study of nab-paclitaxel (nP) with carboplatin (C) and thoracic radiation (TRT) in patients with locally advanced NSCLC
    Keedy, V. L.
    Lu, B.
    Horn, L.
    Shyr, Y.
    Winkler, C. F.
    Carbone, D. P.
    Sandler, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [40] Efficacy and safety of nab-paclitaxel or combined nab-paclitaxel and immune checkpoint inhibitors in relapsed small-cell lung cancer
    Wan, Rui
    Guo, Yanrong
    Hao, Xuezhi
    Wang, Zhijie
    Duan, Jianchun
    Wang, Jie
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
12345